Sunshine Biopharma (SBFM) Competitors $2.13 -0.05 (-2.29%) (As of 12:35 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SBFM vs. ONVO, RNAZ, DFFN, KPRX, MBIO, TRIB, SNTI, IMNN, AYTU, and ONCOShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include Organovo (ONVO), TransCode Therapeutics (RNAZ), Diffusion Pharmaceuticals (DFFN), Kiora Pharmaceuticals (KPRX), Mustang Bio (MBIO), Trinity Biotech (TRIB), Senti Biosciences (SNTI), Imunon (IMNN), Aytu BioPharma (AYTU), and Onconetix (ONCO). These companies are all part of the "medical" sector. Sunshine Biopharma vs. Organovo TransCode Therapeutics Diffusion Pharmaceuticals Kiora Pharmaceuticals Mustang Bio Trinity Biotech Senti Biosciences Imunon Aytu BioPharma Onconetix Sunshine Biopharma (NASDAQ:SBFM) and Organovo (NASDAQ:ONVO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, community ranking, earnings, dividends and profitability. Does the media favor SBFM or ONVO? In the previous week, Organovo had 2 more articles in the media than Sunshine Biopharma. MarketBeat recorded 2 mentions for Organovo and 0 mentions for Sunshine Biopharma. Organovo's average media sentiment score of 0.80 beat Sunshine Biopharma's score of 0.00 indicating that Organovo is being referred to more favorably in the news media. Company Overall Sentiment Sunshine Biopharma Neutral Organovo Positive Which has more volatility & risk, SBFM or ONVO? Sunshine Biopharma has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Organovo has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Is SBFM or ONVO more profitable? Sunshine Biopharma has a net margin of -12.82% compared to Organovo's net margin of -12,176.70%. Sunshine Biopharma's return on equity of -17.89% beat Organovo's return on equity.Company Net Margins Return on Equity Return on Assets Sunshine Biopharma-12.82% -17.89% -14.25% Organovo -12,176.70%-249.28%-159.50% Do institutionals and insiders hold more shares of SBFM or ONVO? 42.0% of Sunshine Biopharma shares are held by institutional investors. Comparatively, 8.2% of Organovo shares are held by institutional investors. 0.1% of Sunshine Biopharma shares are held by company insiders. Comparatively, 3.7% of Organovo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, SBFM or ONVO? Sunshine Biopharma has higher revenue and earnings than Organovo. Organovo is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSunshine Biopharma$24.09M0.11-$4.51M-$150.88-0.01Organovo$110K48.90-$14.67M-$1.06-0.33 Does the MarketBeat Community favor SBFM or ONVO? Organovo received 195 more outperform votes than Sunshine Biopharma when rated by MarketBeat users. However, 100.00% of users gave Sunshine Biopharma an outperform vote while only 47.80% of users gave Organovo an outperform vote. CompanyUnderperformOutperformSunshine BiopharmaOutperform Votes1100.00% Underperform VotesNo VotesOrganovoOutperform Votes19647.80% Underperform Votes21452.20% SummarySunshine Biopharma beats Organovo on 9 of the 15 factors compared between the two stocks. Ad DTIMan behind OpenAI makes shocking new betBillionaire Sam Altman has become one of the most powerful men in the world by running OpenAI… But there’s a far lesser known investment he’s making that could put OpenAI to shame. In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI… And the US Military… not to mention hundreds of other giant companies around the globe. To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office… Which ordered the government to take this incredible new technology seriously.Check out our report right here. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.62M$6.49B$5.09B$8.79BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.015.3293.0914.02Price / Sales0.11370.921,220.6787.41Price / CashN/A52.5939.4936.27Price / Book0.1110.236.936.33Net Income-$4.51M$153.22M$118.83M$225.71M7 Day Performance-16.34%-1.99%-1.74%-0.58%1 Month Performance-29.74%-7.51%-3.60%1.49%1 Year Performance-91.04%31.02%31.91%27.23% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma0.0831 of 5 stars$2.13-2.3%N/A-91.9%$2.60M$24.09M-0.013ONVOOrganovo0.6793 of 5 stars$0.33-5.7%N/A-72.7%$5.07M$110,000.00-0.3320Analyst ForecastNews CoverageRNAZTransCode Therapeutics2.651 of 5 stars$0.36+7.6%$3.00+729.4%-96.3%$6.25MN/A0.009DFFNDiffusion PharmaceuticalsN/AN/AN/AN/A$8.98MN/A0.0013Gap UpHigh Trading VolumeKPRXKiora Pharmaceuticals2.9909 of 5 stars$3.39-0.9%$10.00+195.0%-32.4%$10.17MN/A0.0010MBIOMustang Bio1.9526 of 5 stars$0.21+0.3%$2.00+854.2%-87.6%$10.02MN/A-0.13100TRIBTrinity Biotech1.8381 of 5 stars$1.28-1.5%N/A-33.5%$9.75M$56.83M-0.58480SNTISenti Biosciences1.0644 of 5 stars$2.12flatN/A-42.1%$9.73M$2.56M-0.144News CoverageIMNNImunon2.7233 of 5 stars$0.66-3.5%$12.00+1,717.9%-26.5%$9.57M$500,000.00-0.3633Gap DownAYTUAytu BioPharma1.33 of 5 stars$1.52+2.0%N/A-37.9%$9.34M$81M0.00160ONCOOnconetix0.2078 of 5 stars$1.09+0.9%N/AN/A$9.04M$60,000.000.0012 Related Companies and Tools Related Companies ONVO Competitors RNAZ Competitors DFFN Competitors KPRX Competitors MBIO Competitors TRIB Competitors SNTI Competitors IMNN Competitors AYTU Competitors ONCO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SBFM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBFM Stock Alerts